Tech companies are utilizing artificial intelligence to support studies and trying to boost the capabilities of cancer detection, research, and treatment.

These include an AI platform that is currently under development for cancer treatment and involves Dell Technologies and the University of Limerick's Digital Cancer Research Center. They are trying to develop an artificial intelligence platform that is designed to help clinicians provide more effective cancer care for patients with B-cell lymphoma.

Using Artificial Intelligence To Support Cancer Patients

The platform, which was initially created by Dell for UL, delivers high-performance computing power to accelerate oncology and precision medicine research. It would also introduce cancer patient digital twins for better diagnostics.

A digital twin is a virtual model that is designed to accurately reflect a physical object for professionals to observe and study. Dell said that using the new AI platform, researchers will be able to rapidly accelerate biomarker testing for cancer, gain an advance understanding of how to treat patients with B-cell lymphoma and develop personalized therapies based on an individual's tumor characteristics, as per RTE.

In a statement, professor of Molecular Pathology at the University of Limerick and Director of the Digital Pathology Unit at the Digital Cancer Research Center, Paul Murray, said that through their partnership with the Dell Technologies team, they were able to advance their knowledge of how humans' cells go wrong during cancer development. They also found new ways to diagnose and treat cancer patients.

The Managing Director of Dell Technologies Ireland, Catherine Doyle, said that the new AI platform would ultimately help researchers and healthcare professionals deliver precision treatments for patients who have B-cell lymphoma by understanding how it actually develops.

Doyle noted that through the creation of the so-called digital twins, the University of Limerick and Dell were able to take clinical research to a whole new level. She added that with their cooperation, they were able to harness the power of data through new technologies to benefit patients and healthcare professionals worldwide.

Read Also: Musk Plans To Meld Neuralink, Tesla, Into One AI Company Known as xAI 

Advancement in Medical Technology

On the other hand, Microsoft is partnering with the digital pathology company Paige in an effort to build the world's largest image-based artificial intelligence model that would assist in detecting cancer, according to Fox News.

The new model will be used for digital pathology and oncology and will be configured with billions of parameters that would provide a computer vision AI that is much larger than any similar model that currently exists.

The founder and chief scientist of Paige, Dr. Thomas Fuchs, said that the amount of data that was used in the model is "orders of magnitude" larger than anything that has been made public by Google or Facebook.

The model would help professionals capture the subtle complexities of cancer and will serve as the cornerstone for the next generation of clinical applications that push the boundaries of oncology and pathology.

The newly designed artificial intelligence will be able to identify both common cancers and rare cancers that are notorious for being difficult to diagnose. The Vice President and Managing Director of Microsoft Health Futures, Desney Tan, said that they are in the process of making AI models that will provide unprecedented insights into the pathology of cancer, said Gulf News.

Related Article: Google Issues New Guidelines for AI-Generated 2024 US Election Ads